Cargando…

Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study

BACKGROUND: Despite the potentially accompanying negative clinical, epidemiologic, and health economic effects, a large proportion of persons living with the human immunodeficiency virus (HIV) are diagnosed late. Internationally, numerous diseases are known to be HIV indicator diseases. Adequate HIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valbert, Frederik, Koppe, Uwe, Schmidt, Daniel, Krings, Amrei, Gunsenheimer-Bartmeyer, Barbara, Dröge, Patrik, Ruhnke, Thomas, Behrens, Georg, Bickel, Markus, Boesecke, Christoph, Esser, Stefan, Wasem, Jürgen, Neumann, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464271/ https://www.ncbi.nlm.nih.gov/pubmed/37626414 http://dx.doi.org/10.1186/s13690-023-01161-9

Ejemplares similares

Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study
por: Koppe, Uwe, et al.
Publicado: (2019)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
por: Koppe, Uwe, et al.
Publicado: (2021)

The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany
por: Pantke, Annemarie, et al.
Publicado: (2022)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

HeLP-Diabetes: randomised controlled trial protocol
por: Murray, Elizabeth, et al.
Publicado: (2015)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

HeLP: Development of occupational protection mask against surgical smoke
por: Leachi, Helenize Ferreira Lima, et al.
Publicado: (2023)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o
por: Wang, Bo, et al.
Publicado: (2019)

Evaluating the implementation of HeLP-Diabetes within NHS services: study protocol
por: Ross, Jamie, et al.
Publicado: (2014)

Evaluation der Einführung der HIV-Präexpositionsprophylaxe als Leistung der gesetzlichen Krankenversicherung (EvE‑PrEP): Hocheffektiver Schutz vor HIV und keine Zunahme von sexuell übertragbaren Infektionen
por: Schmidt, Daniel, et al.
Publicado: (2023)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review
por: Boesecke, Christoph, et al.
Publicado: (2023)

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2020)

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Effectiveness and implementation of an obesity prevention intervention: the HeLP-her Rural cluster randomised controlled trial
por: Lombard, Catherine B, et al.
Publicado: (2014)

Healthy Lifestyle Program (HeLP) for low back pain: protocol for a randomised controlled trial
por: Robson, Emma K, et al.
Publicado: (2019)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

Depression and Anxiety in Heart Transplant Recipients: Prevalence and Impact on Post-Transplant Outcomes
por: Alyaydin, Emyal, et al.
Publicado: (2023)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort
por: Crowell, Trevor A., et al.
Publicado: (2021)

Limiting postpartum weight retention through early antenatal intervention: the HeLP-her randomised controlled trial
por: Harrison, Cheryce L, et al.
Publicado: (2014)

Crossing the Digital Divide in Online Self-Management Support: Analysis of Usage Data From HeLP-Diabetes
por: Poduval, Shoba, et al.
Publicado: (2018)

Orang Asli Health and Lifeways Project (OA HeLP): a cross-sectional cohort study protocol
por: Wallace, Ian J, et al.
Publicado: (2022)

Health literacy in patients with pulmonary embolism: development and validation of the HeLP (Health Literacy in Pulmonary Embolism)-Questionnaire
por: Fischer, Simone, et al.
Publicado: (2023)

One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis
por: Speckemeier, Christian, et al.
Publicado: (2022)

Prevalence of hepatitis B and C, HIV, and syphilis among people who inject drugs in Germany
por: Steffen, G, et al.
Publicado: (2022)

Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016
por: Krings, Amrei, et al.
Publicado: (2021)

Qualitative findings from an exploratory trial of the Healthy Lifestyles Programme (HeLP) and their implications for the process evaluation in the definitive trial
por: Lloyd, Jenny J, et al.
Publicado: (2014)

The Health Literacy in Pregnancy (HeLP) Program Study Protocol: Development of an Antenatal Care Intervention Using the Ophelia Process
por: Meldgaard, Maiken, et al.
Publicado: (2022)

Protocol for the development and validation of a patient-reported experience measure (PREM) for people with hearing loss: the PREM-HeLP
por: Pryce, Helen, et al.
Publicado: (2023)

Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis
por: Engelbertz, Christiane, et al.
Publicado: (2023)

Association of age with 1-year outcome in patients with acute ischaemic stroke treated with thrombectomy: real-world analysis in 18 506 patients
por: Beuker, Carolin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ck82bvi1em0ie876oh47d263ln